Erlanger Health System and Vanderbilt-Ingram Cancer Center announced June 26 a new agreement designating VICC as Erlanger's only contracted provider of inpatient and outpatient hematology and oncology services.
Oncology
The FDA will create a website to host information on patient-reported symptoms from cancer-related clinical trials, making it more easily accessible to the public and healthcare professionals.
Blood tests can serve as an accurate, less-invasive method for brain tumor diagnostics and categorization, according to a study published June 22 in Nature Medicine.
U.S. oncologists experienced high anxiety rates at the beginning of the COVID-19 pandemic, a new study shows.
Iowa City-based University of Iowa Health Care has tested nearly 100 former cancer patients for the presence of leftover cancer DNA through the use of a liquid biopsy, according to NBC affiliate KWQC-TV.
New York University Langone Health in New York City launched a service that will enable people to connect with cancer specialists virtually.
As the COVID-19 pandemic slows cancer care and research, the director of Bethesda, Md.-based National Cancer Institute is worried that the country may trade one public health crisis for another involving cancer patients, STAT News reports.
U.S. cancer survivors with financial difficulties are more likely to visit the emergency department, a new study shows.
Tampa, Fla.-based Moffitt Cancer Center will begin construction on its 10-story, $400 million hospital in July, according to The Tampa Bay Business Journal.
Though patient enrollment in clinical trials for cancer therapies has slowed as a result of the COVID-19 pandemic, and some institutions have halted trials altogether, other trials are continuing with modified protocols, according to STAT News.